Synod Pharmaceuticals Private Limited
About Synod Pharmaceuticals Private Limited
Data last updated:
Synod Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 08 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC143438. Its GSTIN is 07AAJCS6729E1Z5 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kamal Bhushan and Charanpreet Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – Pra – 2B Pratap Nagar Metro Station, New Delhi, Delhi, India – 110007.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.56 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹41,284 (net margin 0.7%) and EBITDA of ₹1 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No – Pra – 2B Pratap Nagar Metro Station, New Delhi, Delhi, India – 110007
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Synod Pharmaceuticals Private Limited
The main business activity of Synod Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synod Pharmaceuticals Private Limited FY 2025 filings available
Synod Pharmaceuticals Private Limited reported revenue of ₹60.56 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Synod Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 5% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synod Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹41,284 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synod Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synod Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Synod Pharmaceuticals Private Limited
Synod Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Velens Pharmaceuticals Private Limited | ₹60.76 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Narshingpur, Madhya Pradesh, India |
| Akimoto Pharmaceuticals Private Limited | ₹60.66 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| VNH Pharmaceuticals Private Limited | ₹60.62 Lakh (FY 2021) | •••• | •••• | -38.0% | •••• | Shameerpet, Telangana, India |
| Cisza Pharmaceuticals Private Limited | ₹60.58 Lakh (FY 2025) | •••• | •••• | 38.0% | •••• | Aurangabad, Maharashtra, India |
| Spiffy Pharmaceuticals India Private Limited | ₹60.56 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Pune, Maharashtra, India |
| Synod Pharmaceuticals Private Limited this company | ₹60.56 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Medrain Life Pharmaceuticals (OPC) Private Limited | ₹60.36 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Nagaon, Assam, India |
| Meglife Pharmaceuticals Private Limited | ₹60.21 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Chennai, Tamil Nadu, India |
| Oberto Pharmaceuticals Private Limited | ₹60.15 Lakh (FY 2020) | •••• | •••• | 266.0% | •••• | Manimajra, Chandigarh, India |
| Trividha Pharmaceuticals Private Limited | ₹60.14 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Noida, Uttar Pradesh, India |
| Divergent Pharmaceuticals Private Limited | ₹60.12 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Synod Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Synod Pharmaceuticals Private Limited
Synod Pharmaceuticals Private Limited is audited by BANWAIT AGGARWAL AND CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BANWAIT AGGARWAL AND CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Synod Pharmaceuticals Private Limited
Synod Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Bhushan | Director | 08 Dec 2005 | 20 Years 10 Months | Current |
| Charanpreet Singh | Director | 08 Dec 2005 | 20 Years 10 Months | Current |
| Rajesh Sehgal | Director | 08 Dec 2005 | 20 Years 10 Months | Current |
Ownership and Shareholding of Synod Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synod Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2014 | Oriental Bank of Commerce | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Synod Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Synod Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Synod Pharmaceuticals Private Limited
Synod Pharmaceuticals Private Limited has 3 board changes on record since 2005: 3 appointments. The latest: Charanpreet Singh was appointed as Director on 08 Dec 2005.
Credit Ratings, Litigation & Regulatory Alerts for Synod Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synod Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synod Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synod Pharmaceuticals Private Limited
Synod Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCS6729E1Z5 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synod Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synod Pharmaceuticals Private Limited
Synod Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 08 December 2005 (21+ years old) and is registered under CIN U24232DL2005PTC143438.
Synod Pharmaceuticals reported revenue of ₹60.56 Lakh for FY 2025 (up 5% YoY).
Synod Pharmaceuticals has 3 current directors:
- Kamal Bhushan - Director
- Charanpreet Singh - Director
- Rajesh Sehgal - Director
Synod Pharmaceuticals reported a net profit of ₹41,284 (net margin 0.7%) and EBITDA of ₹1 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synod Pharmaceuticals is 8% over three years and 1% over five years. In the latest year (FY 2025) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Synod Pharmaceuticals is 07AAJCS6729E1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Synod Pharmaceuticals is U24232DL2005PTC143438. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synod Pharmaceuticals was incorporated on 08 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Synod Pharmaceuticals by revenue are Velens Pharmaceuticals Private Limited, Akimoto Pharmaceuticals Private Limited, VNH Pharmaceuticals Private Limited, Cisza Pharmaceuticals Private Limited, Spiffy Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Charanpreet Singh was appointed as Director on 08 Dec 2005. Kamal Bhushan was appointed as Director on 08 Dec 2005. Rajesh Sehgal was appointed as Director on 08 Dec 2005.
The registered office of Synod Pharmaceuticals is at Shop No – Pra – 2B Pratap Nagar Metro Station, New Delhi, Delhi, India – 110007.